For Journalists
The Massachusetts Biotechnology Council represents more than 600 biotechnology companies and organizations involved with the industry. We are available to comment and provide background on public policy, economic development, education, workforce development and other key life science issues.
Sarah MacDonald
Media Contact
Director of Communications
MassBio
One Cambridge Center
Cambridge, MA 02142
617-674-5115
Send Email
MassBio Members
View the 600 biotechnology companies, universities, academic institutions that make up our membership list.
Press Kit
MassBio Publications
2009-2010 Federal Policy White Paper
Growing Talent: The Life Sciences Talent Initiative
Biotechnology in Massachusetts
Biotechnology, drug research based on biology rather than chemicals, emerged as an industry separate from traditional pharmaceuticals about 30 years ago. Massachusetts soon became a leader in the young field. After nearly three decades of growth, the state is one of the most significant centers in the world.
Key facts:
- There are more than 400 biotechnology companies in the state, of which 235 are developing therapeutic drugs.
- The industry employs over 45,000 people with a total payroll of more than $4 billion.
- Massachusetts-based biopharmaceutical companies have already developed more than 50 large molecule drugs covering a range of illnesses.
- There are nearly 1,100 biotechnology drugs being developed in Massachusetts, representing close to 8 percent of the global drug pipeline.
MassBio Member News
- February 1, 2012 PCI Synthesis Adds Manufacturing, QC, Business, and R&D Expertise
- January 31, 2012 Mass Life Sciences' $10M grant to help expand Dana-Farber's cancer imaging research program
- January 31, 2012 Biogen Idec Surpasses $5 Billion in 2011 Annual Revenue
- January 30, 2012 Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources
- January 25, 2012 Celgene to Acquire Avila Therapeutics